CGON
$59.85-3.25%
CG Oncology Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.01%US Stock Market 0.007%Russell 3000 0.007%
CG Oncology Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
CG Oncology Inc. total returns by year (2025–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $41.52 | $59.85 | 0.0% | +44.1% | |
| 2025 | $28.68 | $41.52 | 0.0% | +44.8% |
- Annualized
- +19.1%
- 2025–2026
- Average year
- +44.8%
- 1 full years
- Best year
- +44.8%
- 2025
- Worst year
- +44.8%
- 2025
- Positive years
- 1/1
- 100% up
Annualized (CAGR)
+19.1%
2025–2026
Average year
+44.8%
1 full years
Best year
+44.8%
2025
Worst year
+44.8%
2025
Positive years
1/1
100% up
Total return by period#
Annual
-40%-20%0%20%40%
2025+45%'25
2026+44%'26
Methodology#
Total returns, dividends reinvested, measured on CGON. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is CG Oncology Inc.'s average annual return?
- Since 2025, CG Oncology Inc. (CGON) has returned about 19.1% a year (the compound annual growth rate) and an average calendar-year return of 44.8%.
- What were CG Oncology Inc.'s best and worst years?
- Over 2025–2026, the best year was 2025 (+44.8%) and the worst was 2025 (+44.8%).
- How often is CG Oncology Inc. up in a year?
- 1 of the 1 full years since 2025 were positive — about 100% of the time.
More on CG Oncology Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100